BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 25351606)

  • 1. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
    Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C
    Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
    Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
    Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
    Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3.
    Sela U; Dayan M; Hershkoviz R; Lider O; Mozes E
    J Immunol; 2008 Feb; 180(3):1584-91. PubMed ID: 18209054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
    Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
    He XJ; Ding Y; Xiang W; Dang XQ
    Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
    Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
    Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
    Valencia X; Yarboro C; Illei G; Lipsky PE
    J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population.
    Doníz-Padilla L; Martínez-Jiménez V; Niño-Moreno P; Abud-Mendoza C; Hernández-Castro B; González-Amaro R; Layseca-Espinosa E; Baranda-Cándido L
    Lupus; 2011 May; 20(6):628-35. PubMed ID: 21558139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.
    Hu S; Xiao W; Kong F; Ke D; Qin R; Su M
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):549-52. PubMed ID: 18846336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
    Yi Y; McNerney M; Datta SK
    J Immunol; 2000 Dec; 165(11):6627-34. PubMed ID: 11086108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis.
    Zhu Y; Huang Y; Ming B; Wu X; Chen Y; Dong L
    Lupus; 2019 Apr; 28(4):445-454. PubMed ID: 30744525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1,25(OH)
    Ding Y; Liao W; He XJ; Xiang W
    J Cell Mol Med; 2017 May; 21(5):975-985. PubMed ID: 28063200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
    Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.